Foghorn Therapeutics Inc. (FHTX) return on equity (ROE)

Return on equity · fiscal 2022
-97216.1%

Foghorn Therapeutics Inc. (FHTX) earned a return on equity of -97216.1% in fiscal 2022 (the year ended December 31, 2022). That is 97111.5 percentage points lower than the -104.6% of fiscal 2021. Figures as of 18 Nov 2026, 12:48 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2022
-97216.1%
Change on fiscal 2021
−97111.5 pts
Highest on record
-47.1%fiscal 2020
Lowest on record
-97216.1%fiscal 2022
Fiscal years on record
32020–2022

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Foghorn Therapeutics Inc. return on equity (ROE), in more detail

Across the 3 fiscal years on record (2020–2022), the highest was -47.1% in fiscal 2020 and the lowest -97216.1% in fiscal 2022.

History · 3 fiscal years

Return on equity by fiscal year

Foghorn Therapeutics Inc. return on equity (ROE), year by year

Foghorn Therapeutics Inc. (FHTX) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
2022-97216.1% 97111.5 pts down
2021-104.6% 57.5 pts down
2020-47.1%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

More on FHTX

Foghorn Therapeutics Inc., figure by figure

Foghorn Therapeutics Inc. (FHTX) overview: price, valuation and scorecard

Foghorn Therapeutics Inc. return on equity (ROE): questions and answers

What is Foghorn Therapeutics Inc.'s return on equity?

Foghorn Therapeutics Inc. (FHTX) earned a return on equity of -97216.1% in fiscal 2022 (the year ended December 31, 2022). That is 97111.5 percentage points lower than the -104.6% of fiscal 2021.

What are the highest and lowest return on equity figures on record for Foghorn Therapeutics Inc.?

Across the 3 fiscal years on record (2020–2022), the highest was -47.1% in fiscal 2020 and the lowest -97216.1% in fiscal 2022.

How is Foghorn Therapeutics Inc.'s return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative. For Foghorn Therapeutics Inc. it is on record here for 3 fiscal years, 2020 to 2022.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Foghorn Therapeutics Inc. (FHTX) return on equity (ROE)”, data as of 18 November 2026. https://funkfolio.com/stock/FHTX/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.